Formulary Search Results for: ALENDRONIC ACID
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
Restrictions:
Restricted to patients who are unable to swallow tablets where alendronic acid is the appropriate treatment choice
Prescribing Notes:
- Please note that the effervescent formulation is subject to the same administration requirements as the standard tablets.
- The cost differential between the effervescent tablet and the standard tablet formulation is significant. Consider whether alternative non-oral options may be more suitable (may require discussion with specialist service).
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
Prescribing Notes:
First line bisphosphonate for osteoporosis. The 70mg once a week standard tablet preparation is the preferred formulation (except in men, where only the daily 10mg preparation is licensed).
For other preparations, see the Total Formulary
13.8.1.2 Conditions associated with photodamage - View Category
Restrictions:
- Restricted to use by Consultant Dermatologists for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp (Olsen grade 1 to 2).
- Restricted to specialist use for the treatment of superficial and/or nodular basal cell carcinoma (BCC) in adults unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome.
11.3.1 Antibacterials - View Category
9.1.2 Drugs used in megaloblastic anaemias - View Category
Prescribing Notes:
Used for folate deficiency and prophylaxis for the prevention of neural tube defects in pregnancy. To prevent first occurrence of neural tube defects, women planning a pregnancy should take folic acid 400 micrograms daily before conception and during the first 12 weeks of pregnancy. Women, who suspect they are pregnant but have not been taking folic acid, should start at once and continue until the 12th week of pregnancy. Women with a previous pregnancy affected by a neural tube defect should take folic acid 5mg daily. Women taking antiepileptic drugs may also be advised to take higher doses of folic acid.
9.8.2 Acute porphyrias - View Category
Restrictions: This is an orphan product. Restricted to use by experts providing the supraregional specialist service for N-acetylglutamate synthase deficiency. Use for hyperammonaemia due to isovaleric acidaemia, methylmalonic acidaemia and propionic acidaemia is restricted to specialist use.
8.2.1 Antiproliferative immunosuppressants - View Category
Restrictions:
Restricted to specialist initiation. Restricted to use by transplant specialists as part of an immunosuppressive regimen.
Prescribing Notes:
The preferred brand in NHSGGC is Ceptava®